Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Abstract
It is generally thought that many drug molecules are transported across biological membranes via passive diffusion at a rate related to their lipophilicity. However, the types of biophysical forces involved in the interaction of drugs with lipid membranes are no different from those involved in their interaction with proteins, and so arguments based on lipophilicity could also be applied to drug uptake by membrane transporters or carriers. In this article, we discuss the evidence supporting the idea that rather than being an exception, carrier-mediated and active uptake of drugs may be more common than is usually assumed - including a summary of specific cases in which drugs are known to be taken up into cells via defined carriers - and consider the implications for drug discovery and development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Note that despite a widespread assumption that lipophilicity or log P is sufficient to account for drug distribution this is not in fact the case, as there are hundreds of natural transporters that drugs can use (e.g. [18,1714]).”
In the citing paper
“(Note that liophilicity per se may not be relevant, as drugs require carriers to cross membranes [18], and promiscuity and off-target effects increase with lipophilicity [1679].)”
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
CHEMIOSMOTIC COUPLING IN OXIDATIVE AND PHOTOSYNTHETIC PHOSPHORYLATION
MITCHELL, P. (1966) · Biological Reviews · doi:10.1111/j.1469-185x.1966.tb01501.x · Cited by 3,663
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Hucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
The Membrane Actions of Anesthetics and Tranquilizers
Seeman, P. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06931-5 · Cited by 2,246
Abraham, M. H. (1993) · Chemical Society Reviews · doi:10.1039/cs9932200073 · Cited by 1,968
Osmotic Stress Signaling and Osmoadaptation in Yeasts
Hohmann, S. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.2.300-372.2002 · Cited by 1,767
Mammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics
Uhlén, M., Björling, E., Agaton, C., Szigyarto, C. A.-K., Amini, B., Andersen, E., Andersson, A.-C., Angelidou, P., Asplund, A., Asplund, C., et al. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500279-mcp200 · Cited by 1,540
Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
Hubatsch, I., Ragnarsson, E. G. E., & Artursson, P. (2007) · Nature Protocols · doi:10.1038/nprot.2007.303 · Cited by 1,499
Reconstitution of Cell Membrane Structure in vitro and its Transformation into an Excitable System
MUELLER, P., RUDIN, D. O., TI TIEN, H., & WESCOTT, W. C. (1962) · Nature · doi:10.1038/194979a0 · Cited by 1,404
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., & Palsson, B. Ø. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610772104 · Cited by 1,374
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304
Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors
Mihic, S. J., Ye, Q., Wick, M. J., Koltchine, V. V., Krasowski, M. D., Finn, S. E., Mascia, M. P., Valenzuela, C. F., Hanson, K. K., Greenblatt, E. P., et al. (1997) · Nature · doi:10.1038/38738 · Cited by 1,219
High throughput artificial membrane permeability assay for blood–brain barrier
Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00012-6 · Cited by 1,195
How lipids affect the activities of integral membrane proteins
Lee, A. G. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.05.012 · Cited by 1,194
Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191
Regulation of Metabolic Processes in Mitochondria
(1967) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(67)83077-3 · Cited by 1,182
Aquaporin water channels – from atomic structure to clinical medicine
Agre, P., King, L. S., Yasui, M., Guggino, W. B., Ottersen, O. P., Fujiyoshi, Y., Engel, A., & Nielsen, S. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.020818 · Cited by 1,139
Finding function in novel targets: C. elegans as a model organism
Kaletta, T., & Hengartner, M. O. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2031 · Cited by 1,093
Hagenbuch, B., & Meier, P. J. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1168-y · Cited by 1,019
THE CELL BIOLOGY OF THE BLOOD-BRAIN BARRIER
Rubin, L. L., & Staddon, J. M. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.11 · Cited by 1,000
Hediger, M. A., Romero, M. F., Peng, J.-B., Rolfs, A., Takanaga, H., & Bruford, E. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1192-y · Cited by 985
Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
Babine, R. E., & Bender, S. L. (1997) · Chemical Reviews · doi:10.1021/cr960370z · Cited by 892
Multiple molecular mechanisms for multidrug resistance transporters
Higgins, C. F. (2007) · Nature · doi:10.1038/nature05630 · Cited by 860
Bowman, W. C., & Rand, M. J. (1980) · Biblioteca Digital (Real Academia Nacional de Medicina) · Cited by 859
Saier, M. H. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj001 · Cited by 858
PARSEGIAN, A. (1969) · Nature · doi:10.1038/221844a0 · Cited by 854
The model organism as a system: integrating 'omics' data sets
Joyce, A. R., & Palsson, B. Ø. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1857 · Cited by 785
Aggregation and vesiculation of membrane proteins by curvature-mediated interactions
Reynwar, B. J., Illya, G., Harmandaris, V. A., Müller, M. M., Kremer, K., & Deserno, M. (2007) · Nature · doi:10.1038/nature05840 · Cited by 761
The mitochondrial transporter family (SLC25): physiological and pathological implications
Palmieri, F. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1099-7 · Cited by 756
Yanagida, O., Kanai, Y., Chairoungdua, A., Kim, D. K., Segawa, H., Nii, T., Cha, S. H., Matsuo, H., Fukushima, J.-I., Fukasawa, Y., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00384-4 · Cited by 746
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 723
EVOLUTION OF THE ATP-BINDING CASSETTE (ABC) TRANSPORTER SUPERFAMILY IN VERTEBRATES
Dean, M., & Annilo, T. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162122 · Cited by 650
Tamai, I., Nezu, J.-I., Uchino, H., Sai, Y., Oku, A., Shimane, M., & Tsuji, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2922 · Cited by 642
A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)
Hsiang, B., Zhu, Y., Wang, Z., Wu, Y., Sasseville, V., Yang, W.-P., & Kirchgessner, T. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37161 · Cited by 641
Cloning and Characterization of Two Human Polyspecific Organic Cation Transporters
GORBOULEV, V., ULZHEIMER, J. C., AKHOUNDOVA, A., ULZHEIMER-TEUBER, I., KARBACH, U., QUESTER, S., BAUMANN, C., LANG, F., BUSCH, A. E., & KOEPSELL, H. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.871 · Cited by 638
Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter
Sekine, T., Watanabe, N., Hosoyamada, M., Kanai, Y., & Endou, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18526 · Cited by 625
Ho, R. H., Tirona, R. G., Leake, B. F., Glaeser, H., Lee, W., Lemke, C. J., Wang, Y., & Kim, R. B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.034 · Cited by 611
Dresser, G. K., Bailey, D. G., Leake, B. F., Schwarz, U. I., Dawson, P. A., Freeman, D. J., & Kim, R. B. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.121152 · Cited by 606
OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine
Cvetkovic, M., Leake, B., Fromm, M. F., Wilkinson, G. R., & Kim, R. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15235-x · Cited by 597
Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
Jurd, R., Arrasa, M., Lambert, S., Drexler, B., Siegwart, R., Crestani, F., Zaugg, M., Vogt, K. E., Ledermann, B., Antkowiak, B., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0611fje · Cited by 558
Design of Folic Acid‐Conjugated Nanoparticles for Drug Targeting
Stella, B., Arpicco, S., Peracchia, M. T., Desmaële, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L., & Couvreur, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p · Cited by 553
ABC Transporters and the Blood-Brain Barrier
Begley, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384844 · Cited by 545
Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations
Lee, G., Dallas, S., Hong, M., & Bendayan, R. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01513-8 · Cited by 539
Neurotrophic and Neuroprotective Actions of Estrogens and Their Therapeutic Implications
Lee, S. J., & McEwen, B. S. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.569 · Cited by 534
Zhao, Y. H., Le, J., Abraham, M. H., Hersey, A., Eddershaw, P. J., Luscombe, C. N., Boutina, D., Beck, G., Sherborne, B., Cooper, I., et al. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1031 · Cited by 526
The SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 525
Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast
Parsons, A. B., Lopez, A., Givoni, I. E., Williams, D. E., Gray, C. A., Porter, J., Chua, G., Sopko, R., Brost, R. L., Ho, C.-H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.040 · Cited by 515
Pursuing the leadlikeness concept in pharmaceutical research
Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 515
Cha, S. H., Sekine, T., Fukushima, J.-I., Kanai, Y., Kobayashi, Y., Goya, T., & Endou, H. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12589-8 · Cited by 508
Permeability of small nonelectrolytes through lipid bilayer membranes
Walter, A., & Gutknecht, J. (1986) · The Journal of Membrane Biology · doi:10.1007/bf01870127 · Cited by 502
Transporters as a determinant of drug clearance and tissue distribution
Shitara, Y., Horie, T., & Sugiyama, Y. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.003 · Cited by 496
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492
Impact of Drug Transporter Studies on Drug Discovery and Development
Mizuno, N., Niwa, T., Yotsumoto, Y., & Sugiyama, Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.1 · Cited by 490
Lum, P. Y., Armour, C. D., Stepaniants, S. B., Cavet, G., Wolf, M. K., Butler, J. S., Hinshaw, J. C., Garnier, P., Prestwich, G. D., Leonardson, A., et al. (2004) · Cell · doi:10.1016/s0092-8674(03)01035-3 · Cited by 481
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
Kottra, G., & Daniel, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1101-4 · Cited by 466
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans
Hirano, M., Maeda, K., Shitara, Y., & Sugiyama, Y. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068056 · Cited by 443
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
Wang, D.-S., Jonker, J. W., Kato, Y., Kusuhara, H., Schinkel, A. H., & Sugiyama, Y. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034140 · Cited by 441
Walters, W. P., & Murcko, M. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00003-0 · Cited by 439
The Edinburgh human metabolic network reconstruction and its functional analysis
Ma, H., Sorokin, A., Mazein, A., Selkov, A., Selkov, E., Demin, O., & Goryanin, I. (2007) · Molecular Systems Biology · doi:10.1038/msb4100177 · Cited by 435 · cited 1×
“The availability of the first major versions of the entire human metabolic networ”
BackgroundCloning and Functional Expression of a Human Liver Organic Cation Transporter
Zhang, L., Dresser, M. J., Gray, A. T., Yost, S. C., Terashita, S., & Giacomini, K. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.913 · Cited by 417
Kobayashi, D., Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051300 · Cited by 416
Gao, B., Hagenbuch, B., Kullak-Ublick, G. A., Benke, D., Aguzzi, A., & Meier, P. J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39041-x · Cited by 412
Selection criteria for drug‐like compounds
Muegge, I. (2003) · Medicinal Research Reviews · doi:10.1002/med.10041 · Cited by 412
Lessons Learned from Marketed and Investigational Prodrugs
Ettmayer, P., Amidon, G. L., Clement, B., & Testa, B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303812 · Cited by 384
Nonleadlikeness and leadlikeness in biochemical screening
Rishton, G. M. (2003) · Drug Discovery Today · doi:10.1016/s1359644602025722 · Cited by 381
Transport of Glutamate and Other Amino Acids at the Blood-Brain Barrier
Smith, Q. R. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.4.1016s · Cited by 381
Molecular targets underlying general anaesthesia
Franks, N. P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706441 · Cited by 380
Kameyama, Y., Yamashita, K., Kobayashi, K., Hosokawa, M., & Chiba, K. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000170913.73780.5f · Cited by 379
Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter
Gründemann, D., Schechinger, B., Rappold, G., & Schömig, E. (1998) · Nature Neuroscience · doi:10.1038/1557 · Cited by 374
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
Vavricka, S. R., Van Montfoort, J., Ha, H. R., Meier, P. J., & Fattinger, K. (2002) · Hepatology · doi:10.1053/jhep.2002.34133 · Cited by 373
Wu, X., Kekuda, R., Huang, W., Fei, Y.-J., Leibach, F. H., Chen, J., Conway, S. J., & Ganapathy, V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32776 · Cited by 370
Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)
Lee, W., Glaeser, H., Smith, L. H., Roberts, R. L., Moeckel, G. W., Gervasini, G., Leake, B. F., & Kim, R. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411092200 · Cited by 365
Beaumont, K., Webster, R., Gardner, I., & Dack, K. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489253 · Cited by 363
Transporter-Mediated Permeation of Drugs Across the Blood–Brain Barrier
Tamai, I., & Tsuji, A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1371::aid-jps1>3.0.co;2-d · Cited by 363
Metformin is a Superior Substrate for Renal Organic Cation Transporter OCT2 rather than Hepatic OCT1
Kimura, N., Masuda, S., Tanihara, Y., Ueo, H., Okuda, M., Katsura, T., & Inui, K.-I. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.379 · Cited by 360
Pharmacogenomics of human OATP transporters
König, J., Seithel, A., Gradhand, U., & Fromm, M. F. (2006) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-006-0040-y · Cited by 357
Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human
Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060194 · Cited by 351
Systematic identification of human mitochondrial disease genes through integrative genomics
Calvo, S., Jain, M., Xie, X., Sheth, S. A., Chang, B., Goldberger, O. A., Spinazzola, A., Zeviani, M., Carr, S. A., & Mootha, V. K. (2006) · Nature Genetics · doi:10.1038/ng1776 · Cited by 346
Abe, T., Unno, M., Onogawa, T., Tokui, T., Kondo, T. N., Nakagomi, R., Adachi, H., Fujiwara, K., Okabe, M., Suzuki, T., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.24804 · Cited by 345
Shitara, Y., Itoh, T., Sato, H., Li, A. P., & Sugiyama, Y. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041921 · Cited by 340
EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS
Shitara, Y., Sato, H., & Sugiyama, Y. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121444 · Cited by 336
Identification of multispecific organic anion transporter 2 expressed predominantly in the liver
Sekine, T., Cha, S. H., Tsuda, M., Apiwattanakul, N., Nakajima, N., Kanai, Y., & Endou, H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00585-7 · Cited by 335
Busch, A. E., Karbach, U., Miska, D., Gorboulev, V., Akhoundova, A., Volk, C., Arndt, P., Ulzheimer, J. C., Sonders, M. S., Baumann, C., et al. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.342 · Cited by 332
Lau, Y. Y., Huang, Y., Frassetto, L., & Benet, L. Z. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100038 · Cited by 327
Conversion of biomembrane-produced energy into electric form. I. Submitochondrial particles
Grinius, L. L., Jasaitis, A. A., Kadziauskas, Y. P., Liberman, E. A., Skulachev, V. P., Topali, V. P., Tsofina, L. M., & Vladimirova, M. A. (1970) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(70)90153-2 · Cited by 324
Yabuuchi, H., Tamai, I., Nezu, J.-I., Sakamoto, K., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38199-6 · Cited by 316
Transport of Valganciclovir, a Ganciclovir Prodrug, via Peptide Transporters PEPT1 and PEPT2
Sugawara, M., Huang, W., Fei, Y., Leibach, F. H., Ganapathy, V., & Ganapathy, M. E. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200006)89:6<781::aid-jps10>3.0.co;2-7 · Cited by 312
Neurotransmitter transporters: molecular function of important drug targets
GETHER, U., ANDERSEN, P., LARSSON, O., & SCHOUSBOE, A. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.05.003 · Cited by 309
Multidrug resistance pumps in bacteria: variations on a theme
Lewis, K. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90204-6 · Cited by 306
Drug efflux transporters in the CNS
Sun, H., Dai, H., Shaik, N., & Elmquist, W. F. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00172-2 · Cited by 304
Hydrogen Bonding. 33. Factors That Influence the Distribution of Solutes between Blood and Brain
Abraham, M. H., Chadha, H. S., & Mitchell, R. C. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830915 · Cited by 301
Greene, L. H., Lewis, T. E., Addou, S., Cuff, A., Dallman, T., Dibley, M., Redfern, O., Pearl, F., Nambudiry, R., Reid, A., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl959 · Cited by 300
Systems biology, metabolic modelling and metabolomics in drug discovery and development
Kell, D. B. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.004 · Cited by 297
Self-citationMikkaichi, T., Suzuki, T., Onogawa, T., Tanemoto, M., Mizutamari, H., Okada, M., Chaki, T., Masuda, S., Tokui, T., Eto, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304987101 · Cited by 289
Summerfield, S. G., Read, K., Begley, D. J., Obradovic, T., Hidalgo, I. J., Coggon, S., Lewis, A. V., Porter, R. A., & Jeffrey, P. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121525 · Cited by 283
Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Kobayashi, Y., Yamamoto, T., Cha, S. H., Sekine, T., & Endou, H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.918 · Cited by 276
Dissecting the Chemistry of Protein Splicing and Its Applications
Noren, C. J., Wang, J., & Perler, F. B. (2000) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(20000204)39:3<450::aid-anie450>3.0.co;2-f · Cited by 274
Ohashi, R., Tamai, I., Yabuuchi, H., Nezu, J.-I., Oku, A., Sai, Y., Shimane, M., & Tsuji, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35167-5 · Cited by 273
Nilsson, P., Paavilainen, L., Larsson, K., Ödling, J., Sundberg, M., Andersson, A., Kampf, C., Persson, A., Szigyarto, C. A., Ottosson, J., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500072 · Cited by 265
Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat
Shimizu, K., Ohtaki, K., Matsubara, K., Aoyama, K., Uezono, T., Saito, O., Suno, M., Ogawa, K., Hayase, N., Kimura, K., et al. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02577-x · Cited by 263
Molecular Trojan horses for blood–brain barrier drug delivery
PARDRIDGE, W. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.06.001 · Cited by 260
Current industrial practices of assessing permeability and P-glycoprotein interaction
Balimane, P. V., Han, Y.-H., & Chong, S. (2006) · The AAPS Journal · doi:10.1208/aapsj080101 · Cited by 258
Mitochondrial carriers in the cytoplasmic state have a common substrate binding site
Robinson, A. J., & Kunji, E. R. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509994103 · Cited by 253
Bilayer lipid membranes (BLM) : theory and practice
Tien, H. T. (1974) · M. Dekker eBooks · Cited by 247
Selective Substrates for Non-Neuronal Monoamine Transporters
Gründemann, D., Liebich, G., Kiefer, N., Köster, S., & Schömig, E. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.1 · Cited by 245
Mammalian peptide transporters as targets for drug delivery
Rubio-Aliaga, I., & Daniel, H. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02072-2 · Cited by 240
Bilayer Lipid Membranes (BLM): Theory and Practice
WALKER, N. A. (1975) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1975.tb106250.x · Cited by 232
Cloning and Functional Expression of a Brain Peptide/Histidine Transporter
Yamashita, T., Shimada, S., Guo, W., Sato, K., Kohmura, E., Hayakawa, T., Takagi, T., & Tohyama, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10205 · Cited by 231
CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B
Satoh, H., Yamashita, F., Tsujimoto, M., Murakami, H., Koyabu, N., Ohtani, H., & Sawada, Y. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002337 · Cited by 225
Kodaki, T., & Yamashita, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11408 · Cited by 222
P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design
Raub, T. J. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0500871 · Cited by 221
Drug transport proteins in the liver
Faber, K. N., Müller, M., & Jansen, P. L. M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00173-4 · Cited by 220
Role of transporters in drug interactions
Han, H.-K. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-1107-y · Cited by 220
Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease Inhibitor
Polli, J. W., Jarrett, J. L., Studenberg, S. D., Humphreys, J. E., Dennis, S. W., Brouwer, K. R., & Woolley, J. L. (1999) · Pharmaceutical Research · doi:10.1023/a:1018941328702 · Cited by 218
Nakai, D., Nakagomi, R., Furuta, Y., Tokui, T., Abe, T., Ikeda, T., & Nishimura, K. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29609-9 · Cited by 217
The relationship between permeant size and permeability in lipid bilayer membranes
Xiang, T.-X., & Anderson, B. D. (1994) · The Journal of Membrane Biology · doi:10.1007/bf00232899 · Cited by 215
GRUBE, M., KOCK, K., OSWALD, S., DRABER, K., MEISSNER, K., ECKEL, L., BOHM, M., FELIX, S., VOGELGESANG, S., & JEDLITSCHKY, G. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.09.010 · Cited by 215
Balimane, P. V., Tamai, I., Guo, A., Nakanishi, T., Kitada, H., Leibach, F. H., Tsuji, A., & Sinko, P. J. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9298 · Cited by 214
Structural Basis for the Inhibition of Firefly Luciferase by a General Anesthetic
Franks, N. P., Jenkins, A., Conti, E., Lieb, W. R., & Brick, P. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77664-7 · Cited by 213
(2003) · Wiley eBooks · doi:10.1002/3527601643 · Cited by 213
Isolation of a Family of Organic Anion Transporters from Human Liver and Kidney
Sun, W., Wu, R. R., van Poelje, P. D., & Erion, M. D. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4774 · Cited by 212
Organic Anion Transporter Family: Current Knowledge
Anzai, N., Kanai, Y., & Endou, H. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj06006x · Cited by 209
Genew: the Human Gene Nomenclature Database
Wain, H. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.169 · Cited by 209
LIEB, W. R., & STEIN, W. D. (1969) · Nature · doi:10.1038/224240a0 · Cited by 208
Human Hepatobiliary Transport of Organic Anions Analyzed by Quadruple-Transfected Cells
Kopplow, K., Letschert, K., König, J., Walter, B., & Keppler, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014605 · Cited by 197
TransportDB: a relational database of cellular membrane transport systems
Ren, Q. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh016 · Cited by 195
Drug permeation in biomembranes
Mälkiä, A., Murtomäki, L., Urtti, A., & Kontturi, K. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.05.009 · Cited by 186
Shimizu, M., Fuse, K., Okudaira, K., Nishigaki, R., Maeda, K., Kusuhara, H., & Sugiyama, Y. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004622 · Cited by 183
Participation of a Proton-Cotransporter, MCT1, in the Intestinal Transport of Monocarboxylic Acids
Tamai, I., Takanaga, H., Ogihara, T., Higashida, H., Maeda, H., Sai, Y., & Tsuji, A. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2312 · Cited by 181
Flaten, G. E., Dhanikula, A. B., Luthman, K., & Brandl, M. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.007 · Cited by 180
The role of transporters in drug interactions
Endres, C. J., Hsiao, P., Chung, F. S., & Unadkat, J. D. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.002 · Cited by 179
Terada, T., & Inui, K.-I. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489153 · Cited by 177
Kusuhara, H., & Sugiyama, Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00480-1 · Cited by 177
β-Lactam Antibiotics as Substrates for OCTN2, an Organic Cation/Carnitine Transporter
Ganapathy, M. E., Huang, W., Rajan, D. P., Carter, A. L., Sugawara, M., Iseki, K., Leibach, F. H., & Ganapathy, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1699 · Cited by 175
Summerfield, S. G., Stevens, A. J., Cutler, L., del Carmen Osuna, M., Hammond, B., Tang, S.-P., Hersey, A., Spalding, D. J., & Jeffrey, P. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092916 · Cited by 175
Kullak-Ublick, G., Glasa, J., Boker, C., Oswald, M., Grutzner, U., Hagenbuch, B., Stieger, B., Meier, P., Beuers, U., Kramer, W., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322525 · Cited by 173
Camenisch, G., Folkers, G., & van de Waterbeemd, H. (1996) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(96)00031-3 · Cited by 169
Ren, Q., & Paulsen, I. T. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0010027 · Cited by 164
The Dielectric Constant of Phospholipid Bilayers and the Permeability of Membranes to Ions
Dilger, J. P., McLaughlin, S. G. A., McIntosh, T. J., & Simon, S. A. (1979) · Science · doi:10.1126/science.228394 · Cited by 163
Molecular cloning and tissue distribution of rat peptide transporter PEPT2
Saito, H., Terada, T., Okuda, M., Sasaki, S., & Inui, K.-I. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(96)00024-7 · Cited by 162
New approaches to in vitro models of blood–brain barrier drug transport
Terasaki, T., Ohtsuki, S., Hori, S., Takanaga, H., Nakashima, E., & Hosoya, K.-I. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02858-7 · Cited by 162
An atlas of human gene expression from massively parallel signature sequencing (MPSS)
Jongeneel, C. V., Delorenzi, M., Iseli, C., Zhou, D., Haudenschild, C. D., Khrebtukova, I., Kuznetsov, D., Stevenson, B. J., Strausberg, R. L., Simpson, A. J. G., et al. (2005) · Genome Research · doi:10.1101/gr.4041005 · Cited by 158
The role and structure of mitochondrial carriers
Kunji, E. R. S. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00242-x · Cited by 157
A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis
Hammond, S. M., Claesson, A., Jansson, A. M., Larsson, L.-G., Pring, B. G., Town, C. M., & Ekström, B. (1987) · Nature · doi:10.1038/327730a0 · Cited by 156
Kell, D. B. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05136.x · Cited by 156
Self-citationScientific Perspectives on Drug Transporters and Their Role in Drug Interactions
Zhang, L., Strong, J. M., Qiu, W., Lesko, L. J., & Huang, S. M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050095h · Cited by 153
Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
Wunberg, T., Hendrix, M., Hillisch, A., Lobell, M., Meier, H., Schmeck, C., Wild, H., & Hinzen, B. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03700-1 · Cited by 152
Genew: the Human Gene Nomenclature Database, 2004 updates
Wain, H. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkh072 · Cited by 152
In vitro and pharmacophore insights into CYP3A enzymes
Ekins, S., Stresser, D. M., & Williams, J. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00049-x · Cited by 151
Organic anion transporter (Slc22a) family members as mediators of toxicity
Sweet, D. H. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.016 · Cited by 150 · cited 1×
“However, we note in particular that selective tissue-concentrating mechanisms may also be a cause of toxicit”
BackgroundThe Role of Blood-Brain Barrier Studies in the Pharmaceutical Industry
Reichel, A. (2006) · Current Drug Metabolism · doi:10.2174/138920006775541525 · Cited by 144
Mulato, A. S., Ho, E. S., & Cihlář, T. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38862-7 · Cited by 144
Diffusion of Small Non-Electrolytes across Liposome Membranes
COHEN, B. E., & Bangham, A. D. (1972) · Nature · doi:10.1038/236173a0 · Cited by 139
TISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE
Alnouti, Y., Petrick, J. S., & Klaassen, C. (2006) · Drug Metabolism And Disposition · doi:10.1124/dmd.105.006932 · Cited by 139
A role for intra- and intercellular translocation in natural product biosynthesis
Kutchan, T. M. (2005) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2005.03.009 · Cited by 134
Effects of l ‐dopa and other amino acids against paraquat‐induced nigrostriatal degeneration
McCormack, A. L., & Monte, D. A. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01621.x · Cited by 131
Identification of the Cationic Amino Acid Transporter (System y+) of the Rat Blood‐Brain Barrier
Stoll, J., Wadhwani, K. C., & Smith, Q. R. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13428.x · Cited by 130
Influence of Drug Transporter Polymorphisms on Pravastatin Pharmacokinetics in Humans
Kivistö, K. T., & Niemi, M. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9159-2 · Cited by 130
Determination of the Proton Electrochemical Gradient across Biological Membranes
AZZONE, G. F., Pietrobon, D., & Zoratti, M. (1984) · Current topics in bioenergetics · doi:10.1016/b978-0-12-152513-2.50008-8 · Cited by 129
Wada, S., Tsuda, M., Sekine, T., Ho, S., Kimura, M., Kanai, Y., & Endou, H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39144-x · Cited by 128
Absorption of Peptide and Peptidomimetic Drugs
Amidon, G. L., & Lee, H. J. (1994) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001541 · Cited by 124
Briz, Ó., Serrano, M. A., Rebollo, N., Hagenbuch, B., Meier, P. J., Koepsell, H., & Marı́n, J. J. G. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.4.853 · Cited by 124
Fujikawa, M., Ano, R., Nakao, K., Shimizu, R., & Akamatsu, M. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.076 · Cited by 123
Fungal ATP-Binding Cassette (ABC) Transporters in Drug Resistance & Detoxification
Sipos, G., & Kuchler, K. (2006) · Current Drug Targets · doi:10.2174/138945006776359403 · Cited by 123
On the permeability to weak acids and bases of the cytoplasmic membrane of Clostridiumpasteurianum
Kell, D. B., Peck, M. W., Rodger, G., & Morris, J. G. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91715-0 · Cited by 123
Self-citationSolvent Selection for Whole Cell Biotransformations in Organic Media
Salter, G. J., & Kell, D. B. (1995) · Critical Reviews in Biotechnology · doi:10.3109/07388559509147404 · Cited by 121
Self-citationWallner, M., Hanchar, H. J., & Olsen, R. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600194103 · Cited by 121
Increased Acyclovir Oral Bioavailability via a Bile Acid Conjugate
Tolle‐Sander, S., Lentz, K. A., Maeda, D. Y., Coop, A., & Polli, J. E. (2003) · Molecular Pharmaceutics · doi:10.1021/mp034010t · Cited by 120
Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity
Arendt, R., Greenblatt, D. J., Liebisch, D., Luu, M., & Paul, S. M. (1987) · Psychopharmacology · doi:10.1007/bf02439589 · Cited by 120
Bioactive microbial products : search and discovery
Bu'Lock, J. D., Nisbet, L. J., & Winstanley, D. (1982) · Medical Entomology and Zoology · Cited by 119
Majumdar, S., Duvvuri, S., & Mitra, A. K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.006 · Cited by 114
How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1
Bailey, P. D., Boyd, C. A. R., Bronk, J. R., Collier, I. D., Meredith, D., Morgan, K. M., & Temple, C. S. (2000) · Angewandte Chemie International Edition · Cited by 114
Urakami, Y., Akazawa, M., Saito, H., Okuda, M., & Inui, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019413.78751.46 · Cited by 113
HEPATIC UPTAKE OF THE NOVEL ANTIFUNGAL AGENT CASPOFUNGIN
Sandhu, P., Lee, W., Xu, X., Leake, B. F., Yamazaki, M., Stone, J. A., Lin, J. H., Pearson, P. G., & Kim, R. B. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003244 · Cited by 109
Anaesthetic Drugs: Linking Molecular Actions to Clinical Effects
Grasshoff, C., Drexler, B., Rudolph, U., & Antkowiak, B. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778522038 · Cited by 108
High Throughput Screening: The Discovery of Bioactive Substances
Devlin, J. P. (1997) · Medical Entomology and Zoology · Cited by 107
Fujino, H., Saito, T., Ogawa, S.-I., & Kojima, J. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.10.0009 · Cited by 104
The nature of sites of general anaesthetic action
Miller, K. W. (2002) · British Journal of Anaesthesia · doi:10.1093/bja/aef167 · Cited by 104
Permeability of Lipid Bilayer Membranes to Organic Solutes
Bean, R. C., Shepherd, W. C., & Chan, H. (1968) · The Journal of General Physiology · doi:10.1085/jgp.52.3.495 · Cited by 104
Building an abbreviation dictionary using a term recognition approach
Okazaki, N., & Ananiadou, S. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl534 · Cited by 103
Jones, D. P. (2018) · CRC Press eBooks · doi:10.1201/9781351074575 · Cited by 103
Transporter-mediated drug delivery: recent progress and experimental approaches
Sai, Y., & Tsuji, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03198-8 · Cited by 101
Development and evaluation of an in vitro method for prediction of human drug absorption
Corti, G., Maestrelli, F., Cirri, M., Zerrouk, N., & Mura, P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.005 · Cited by 100
Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1
Tamai, I., Nakanishi, T., Nakahara, H., Sai, Y., Ganapathy, V., Leibach, F. H., & Tsuji, A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980186o · Cited by 100
Human Organic Anion Transporters Mediate the Transport of Tetracycline
Babu, E., Takeda, M., Narikawa, S., Kobayashi, Y., Yamamoto, T., Ho, S., Sekine, T., Sakthisekaran, D., & Endou, H. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.88.69 · Cited by 100
Predicting Drug Absorption: How Nature Made It a Difficult Problem
Burton, P. S., Goodwin, J. T., Vidmar, T. J., & Amore, B. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035006 · Cited by 100
van Montfoort, J. E., Hagenbuch, B., Fattinger, K. E., Müller, M. M., Groothuis, G. M., Meijer, D. K. F., & Meier, P. J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35082-7 · Cited by 100
Planar Lipid Bilayers (BLMs) and Their Applications
Guidelli, R. (2003) · Electrochimica Acta · doi:10.1016/j.electacta.2003.09.001 · Cited by 99
Wenzel, U., Gebert, I., Weintraut, H., Weber, W. M., Clauss, W. G., & Daniel, H. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12941-8 · Cited by 97
Yeast-based functional genomics and proteomics technologies: the first 15 years and beyond
Suter, B., Auerbach, D., & Štagljar, I. (2006) · BioTechniques · doi:10.2144/000112151 · Cited by 96
Tamai, I., Nakanishi, T., Hayashi, K., Terao, T., Sai, Y., Shiraga, T., Miyamoto, K., Takeda, E., Higashida, H., & Tsuji, A. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06115.x · Cited by 95
van Montfoort, J. E., Müller, M. M., Groothuis, G. M. M., Meijer, D. K. F., Koepsell, H., & Meier, P. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29357-5 · Cited by 94
Transporter-mediated Drug Interactions
Tsuji, A. (2002) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.17.253 · Cited by 94
Research works printed but not linked: 1
- Jain, M. K. The Bimolecular Lipid Membrane. (Van Nostrand Reinhold, New York, 1972).
Cited by
Pharmacokinetics and drug metabolism in the elderly
Klotz, U. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902722679 · Cited by 826
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
The impact of natural products upon modern drug discovery
Ganesan, A. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.03.016 · Cited by 646
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
“Consequently, it would be interesting to discuss whether carrier-mediated transport is the ubiquitous and dominant mechanism of biological membrane permeation for most drugs in most organ”
BackgroundUnderstanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Metadata
- Authors
- Dobson, P. D., & Kell, D. B.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Kell, Douglas B.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-03
- Volume
- 7
- Issue
- 3
- Pages
- 205-220
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2157619122
- Cited by
- 475
- References
- 265
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 20 · 2023: 19 · 2022: 18 · 2021: 24 · 2020: 27 · 2019: 20 · 2018: 17 · 2017: 28 · 2016: 36 · 2015: 43 · 2014: 42 · 2013: 29 · 2012: 36
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- Royal Society
- Wolfson Foundation
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council (747/1, BB/D007)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- passive diffusion, lipophilicity, membrane transporters, drug discovery, drug development
- MeSH terms
- Animals, Biological Transport, Cell Membrane, Cell Membrane Permeability, Pharmaceutical Preparations, Humans, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.